Clinical trial
Lumbar Spinal Fibrosis and TNF Alpha Inhibition
NCT00385086 · Assistance Publique - Hôpitaux de Paris, Other · Completed
Key facts
| NCT number | NCT00385086 |
|---|---|
| Title | Lumbar Spinal Fibrosis and TNF Alpha Inhibition |
| Official title | Efficacy of TNF-alpha Inhibition in Sciatica With Post-operative Lumbar Spinal Fibrosis |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Post Operative Sciatica by Lumbar Spinal Fibrosis |
| Intervention type | Drug |
| Interventions | TNF blocker, Placebo |
| Enrollment | 38 |
| Start date | Feb 1, 2007 |
| Primary completion | Oct 1, 2012 |
| Completion | Dec 1, 2014 |
| First posted | Oct 6, 2006 |
| Last update posted | Oct 16, 2015 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: